Scott Gordon | Investor Relations, CORE IR |
Carl Schwartz | President and Chief Executive Officer |
Bob Myers | Chief Financial Officer |
Good afternoon, and welcome to the Precision Therapeutics Earnings Conference Call for the First Quarter Ended March 31, 2019. All participants will be in a listen-only mode. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A replay of the call will be available approximately one hour after the end of the call through June 15, 2019. I would now like to turn the conference call over to Scott Gordon, President of CORE IR, the company's investor relations firm.